BioCentury | Oct 31, 2017
Politics & Policy

Connecticut AG expands generics lawsuit

...president of Mylan N.V. (NASDAQ:MYL; Tel Aviv:MYL), and Satish Mehta, CEO and managing director of Emcure Pharmaceuticals Ltd....
BioCentury | Aug 24, 2017
Translation in Brief

The skinny on leishmaniasis

...and Zydus Cadila Group (NSE:CADILAHC; BSE:532321). In addition, the Infectious Disease Research Institute (IDRI) and Emcure Pharmaceuticals Ltd....
BioCentury | Jun 30, 2014
Financial News

Emcure withdraws IPO

...India Business: Pharmaceuticals, Generics Type: IPO Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital Note: Emcure...
...IPO on the National Stock Exchange of India and Bombay Stock Exchange. In June 2013, Emcure...
BioCentury | Jun 20, 2014
Financial News

Emcure pulls IPO

...up to Rs3 billion ($49.8 million) in the offering. IDFC Capital was coordinating the IPO. Emcure...
BioCentury | Apr 10, 2014
Targets & Mechanisms

Catastrophic vacuolization

...as well as with ionizing radiation." BiCNU carmustine is marketed by Bristol-Myers Squibb Co. and Emcure Pharmaceuticals Ltd....
...MENTIONED Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Technology Ltd. , London, U.K. Emcure Pharmaceuticals Ltd....
BioCentury | Apr 7, 2014
Finance

2Q14 Financial Markets Preview: Minor adjustment

...GeNO LLC 11/12/13 Up to $50M Ph II Vital Therapies Inc. 10/11/13 TBD Ph III Emcure Pharmaceuticals Ltd....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...Biocept Inc. 9/23/13 $20M Mkt (diagnostic) Ruthigen Inc. (C) 8/8/13 $19.5M Start I/II in 1Q14 EmCure Pharmaceuticals Ltd....
BioCentury | Nov 18, 2013
Finance

Thanksgiving break

...in 1Q14 Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (E) 7/23/13 NT$100M ($3.3M) Mkt (drug) EmCure Pharmaceuticals Ltd....
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (C) 7/23/13 NT$100M ($3.3M) Mkt (drug) President Securities EmCure Pharmaceuticals Ltd....
BioCentury | Oct 7, 2013
Finance

4Q Financial Markets Preview: Room to grow - for now

...Ph II Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (B) 7/23/13 NT$100M ($3.3M) Mkt (drug) Emcure Pharmaceuticals Ltd....
Items per page:
1 - 10 of 17
BioCentury | Oct 31, 2017
Politics & Policy

Connecticut AG expands generics lawsuit

...president of Mylan N.V. (NASDAQ:MYL; Tel Aviv:MYL), and Satish Mehta, CEO and managing director of Emcure Pharmaceuticals Ltd....
BioCentury | Aug 24, 2017
Translation in Brief

The skinny on leishmaniasis

...and Zydus Cadila Group (NSE:CADILAHC; BSE:532321). In addition, the Infectious Disease Research Institute (IDRI) and Emcure Pharmaceuticals Ltd....
BioCentury | Jun 30, 2014
Financial News

Emcure withdraws IPO

...India Business: Pharmaceuticals, Generics Type: IPO Underwriters: BofA Merrill Lynch; Morgan Stanley; IDFC Capital Note: Emcure...
...IPO on the National Stock Exchange of India and Bombay Stock Exchange. In June 2013, Emcure...
BioCentury | Jun 20, 2014
Financial News

Emcure pulls IPO

...up to Rs3 billion ($49.8 million) in the offering. IDFC Capital was coordinating the IPO. Emcure...
BioCentury | Apr 10, 2014
Targets & Mechanisms

Catastrophic vacuolization

...as well as with ionizing radiation." BiCNU carmustine is marketed by Bristol-Myers Squibb Co. and Emcure Pharmaceuticals Ltd....
...MENTIONED Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Cancer Research Technology Ltd. , London, U.K. Emcure Pharmaceuticals Ltd....
BioCentury | Apr 7, 2014
Finance

2Q14 Financial Markets Preview: Minor adjustment

...GeNO LLC 11/12/13 Up to $50M Ph II Vital Therapies Inc. 10/11/13 TBD Ph III Emcure Pharmaceuticals Ltd....
BioCentury | Jan 6, 2014
Finance

2014 Financial Markets Preview: Hoping the pause is brief

...Biocept Inc. 9/23/13 $20M Mkt (diagnostic) Ruthigen Inc. (C) 8/8/13 $19.5M Start I/II in 1Q14 EmCure Pharmaceuticals Ltd....
BioCentury | Nov 18, 2013
Finance

Thanksgiving break

...in 1Q14 Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (E) 7/23/13 NT$100M ($3.3M) Mkt (drug) EmCure Pharmaceuticals Ltd....
BioCentury | Oct 28, 2013
Finance

Hoping to give thanks

...Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (C) 7/23/13 NT$100M ($3.3M) Mkt (drug) President Securities EmCure Pharmaceuticals Ltd....
BioCentury | Oct 7, 2013
Finance

4Q Financial Markets Preview: Room to grow - for now

...Ph II Johnson Chemical Pharmaceutical Works Co. Ltd. (GreTai) (B) 7/23/13 NT$100M ($3.3M) Mkt (drug) Emcure Pharmaceuticals Ltd....
Items per page:
1 - 10 of 17